TY - JOUR
T1 - Prone accelerated partial breast irradiation after breast-conserving surgery
T2 - Preliminary clinical results and dose-volume histogram analysis
AU - Formenti, Silvia C.
AU - Truong, Minh Tam
AU - Goldberg, Judith D.
AU - Mukhi, Vandana
AU - Rosenstein, Barry
AU - Roses, Daniel
AU - Shapiro, Richard
AU - Guth, Amber
AU - Dewyngaert, J. Keith
N1 - Funding Information:
Supported by Department of Defense Grant DAMD17-01-1-0345 and NYU Cancer Institute Core Grant.
Funding Information:
In 2000, funded by an IDEA grant from the Department of Defense, a Phase I-II trial was initiated in the Department of Radiation Oncology at New York University to determine the feasibility and efficacy of prone, partial breast conformal RT to the tumor bed in postmenopausal women with T1N0M0 breast cancer who had undergone segmental mastectomy and had refused standard postoperative whole breast RT.
PY - 2004/10/1
Y1 - 2004/10/1
N2 - Purpose To report the clinical and dose-volume histogram results of the first 47 patients accrued to a protocol of accelerated partial breast irradiation. Patients were treated in the prone position with three-dimensional conformal radiotherapy after breast-conserving surgery. Methods and materials Postmenopausal women with Stage T1N0 breast cancer were eligible only after they had first refused to undergo 6 weeks of standard radiotherapy. Planning CT in the prone position was performed on a dedicated table. The postoperative cavity was defined as the clinical target volume, with a 1.5-cm margin added to determine the planning target volume. A total dose of 30 Gy at 6 Gy/fraction was delivered in five fractions within 10 days. Results The median age of the patients was 67.5 years (range, 51-88 years). The median tumor diameter was 9 mm (range, 1.3-19 mm). In all patients, the prescribed dose encompassed the planning target volume. The mean volume of the ipsilateral breast receiving 100% of the prescription dose was 26% (range, 10-45%), and the mean volume contained within the 50% isodose surface was 47% (range, 23-75%). The lung and heart were spared by treating in the prone position. Acute toxicity was modest, limited mainly to Grade 1-2 erythema. With a median follow-up of 18 months, only Grade 1 late toxicity occurred, and no patient developed local recurrence. Conclusion These data suggest that this approach is well tolerated, with only mild acute side effects and sparing of the heart and lung.
AB - Purpose To report the clinical and dose-volume histogram results of the first 47 patients accrued to a protocol of accelerated partial breast irradiation. Patients were treated in the prone position with three-dimensional conformal radiotherapy after breast-conserving surgery. Methods and materials Postmenopausal women with Stage T1N0 breast cancer were eligible only after they had first refused to undergo 6 weeks of standard radiotherapy. Planning CT in the prone position was performed on a dedicated table. The postoperative cavity was defined as the clinical target volume, with a 1.5-cm margin added to determine the planning target volume. A total dose of 30 Gy at 6 Gy/fraction was delivered in five fractions within 10 days. Results The median age of the patients was 67.5 years (range, 51-88 years). The median tumor diameter was 9 mm (range, 1.3-19 mm). In all patients, the prescribed dose encompassed the planning target volume. The mean volume of the ipsilateral breast receiving 100% of the prescription dose was 26% (range, 10-45%), and the mean volume contained within the 50% isodose surface was 47% (range, 23-75%). The lung and heart were spared by treating in the prone position. Acute toxicity was modest, limited mainly to Grade 1-2 erythema. With a median follow-up of 18 months, only Grade 1 late toxicity occurred, and no patient developed local recurrence. Conclusion These data suggest that this approach is well tolerated, with only mild acute side effects and sparing of the heart and lung.
KW - Early-stage breast cancer
KW - Hypofractionation
KW - Partial breast irradiation
KW - Prone
UR - http://www.scopus.com/inward/record.url?scp=4544233332&partnerID=8YFLogxK
U2 - 10.1016/j.ijrobp.2004.04.036
DO - 10.1016/j.ijrobp.2004.04.036
M3 - Article
C2 - 15380584
AN - SCOPUS:4544233332
SN - 0360-3016
VL - 60
SP - 493
EP - 504
JO - International Journal of Radiation Oncology Biology Physics
JF - International Journal of Radiation Oncology Biology Physics
IS - 2
ER -